Achilles Therapeutics PLC (ACHL)
followers
·
Follow
| Sector: | HEALTH CARE |
| Industry: | BIOTECHNOLOGY & LIFE SCIENCES |
| CEO: | Iraj Ali |
| Employees: | 250 |
| Web site: | achillestx.com |
|
245 HAMMERSMITH ROAD, LONDON, X0, W6 8PW
44 (0)20 8154 4600
| |
| All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
|---|
Achilles Therapeutics Plc develops precision T cell therapies to treat various solid tumors. The company's lead product candidates include CHIRON, which is in Phase I/IIa clinical trial for use in the treatment of advanced non-small cell lung cancer; THETIS, a product candidate in clinical trials for use of metastatic or recurrent melanoma. Achilles is headquartered in London, the United Kingdom.